UBS Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,979
Closed -$12K 9964
2021
Q3
$12K Hold
1,979
﹤0.01% 6703
2021
Q2
$16K Sell
1,979
-21,702
-92% -$175K ﹤0.01% 6519
2021
Q1
$211K Buy
23,681
+14,671
+163% +$131K ﹤0.01% 4478
2020
Q4
$104K Buy
9,010
+1,202
+15% +$13.9K ﹤0.01% 4684
2020
Q3
$81K Sell
7,808
-4,715
-38% -$48.9K ﹤0.01% 4473
2020
Q2
$165K Sell
12,523
-131
-1% -$1.73K ﹤0.01% 4133
2020
Q1
$100K Sell
12,654
-7,130
-36% -$56.3K ﹤0.01% 4440
2019
Q4
$410K Sell
19,784
-89,743
-82% -$1.86M ﹤0.01% 4055
2019
Q3
$1.5M Buy
109,527
+49,739
+83% +$682K ﹤0.01% 2867
2019
Q2
$736K Buy
59,788
+38,129
+176% +$469K ﹤0.01% 3250
2019
Q1
$270K Sell
21,659
-259,054
-92% -$3.23M ﹤0.01% 3686
2018
Q4
$3.18M Buy
280,713
+209,392
+294% +$2.37M ﹤0.01% 2059
2018
Q3
$1.34M Buy
71,321
+19,760
+38% +$370K ﹤0.01% 2915
2018
Q2
$1.33M Sell
51,561
-124,950
-71% -$3.23M ﹤0.01% 2850
2018
Q1
$3.96M Buy
176,511
+132,279
+299% +$2.96M ﹤0.01% 2035
2017
Q4
$1.11M Buy
44,232
+11,153
+34% +$279K ﹤0.01% 2952
2017
Q3
$799K Buy
33,079
+15,450
+88% +$373K ﹤0.01% 3144
2017
Q2
$357K Buy
17,629
+14,954
+559% +$303K ﹤0.01% 3566
2017
Q1
$72K Sell
2,675
-1,027
-28% -$27.6K ﹤0.01% 4399
2016
Q4
$70K Buy
3,702
+1,197
+48% +$22.6K ﹤0.01% 4667
2016
Q3
$49K Sell
2,505
-69
-3% -$1.35K ﹤0.01% 4678
2016
Q2
$39K Buy
2,574
+2,255
+707% +$34.2K ﹤0.01% 4857
2016
Q1
$3K Buy
+319
New +$3K ﹤0.01% 6358
2015
Q4
Sell
-68
Closed -$1K 7073
2015
Q3
$1K Sell
68
-130
-66% -$1.91K ﹤0.01% 6734
2015
Q2
$4K Buy
+198
New +$4K ﹤0.01% 6388
2015
Q1
Sell
-1,125
Closed -$23K 6874
2014
Q4
$23K Buy
+1,125
New +$23K ﹤0.01% 5400